Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 14;12(2):269–281. doi: 10.1016/j.tranon.2018.09.015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Supplementary Figure 5 — IHC results of tumor xenografts.

The patient-derived tumor tissues xenografted on mice were stained with IHC of MDM2. IHC was carried out serially about tumor tissues engrafted on mice (from G0 to G3) in order to determine whether it maintained the inherent character of liposarcoma. (A) Primary tumor (14GS-032: Xeno-G0), (B) xenografted F1 tumor (14GS-032: Xeo-G1), (C) xenografted F2 (14GS-032: Xeno-G2), (D) xenografted F3 (14GS-032: Xeno-G3), and (E) xenografted F1 tumor (15GS-002-2: Xeo-G1).

Supplementary Figure 5 — IHC results of tumor xenografts.

The patient-derived tumor tissues xenografted on mice were stained with IHC of MDM2. IHC was carried out serially about tumor tissues engrafted on mice (from G0 to G3) in order to determine whether it maintained the inherent character of liposarcoma. (A) Primary tumor (14GS-032: Xeno-G0), (B) xenografted F1 tumor (14GS-032: Xeo-G1), (C) xenografted F2 (14GS-032: Xeno-G2), (D) xenografted F3 (14GS-032: Xeno-G3), and (E) xenografted F1 tumor (15GS-002-2: Xeo-G1).